Cells 10 , 1591 (2021)
Quick Answer: No formal contraindication exists for taking NAD+ supplements with tirzepatide, but this combination has not been studied in clinical trials and safety has not been established
(PDF) Trivedi, M.H., McGrath, P.J., Fava, M., Parsey, R.V., Kurian, B.T., Phillips, M.L., Oquendo, M.A., Bruder, G., Pizzagalli, D., Toups, M., Cooper, C., Adams, P., Weyandt, S., Morris, D.W., Grannemann, B., Ogden, R.T., Buckner, R., McInnis, M., Kraemer, H.C., Petkova, E., Carmody, T.J., Weissman, M.M
While liraglutide has slightly higher GLP-1R affinity, semaglutide has an extended half-life due to its albumin-binding abilities
Strategic shift: Novo Nordisk is actively winding down legacy and lower-margin insulin products, especially in developed markets, to prioritize next-generation basal insulins (Tresiba, Awiqli) and innovative GLP-1 therapies